| GSK-3326595 |
GSK-3326595 |
1616392-22-3 |
| ML 133 Hydrochloride |
(4-甲氧基苄基)(1-萘基甲基)胺盐酸盐 |
1222781-70-5 |
| PFI-1 |
PFI-1 (PF-6405761) |
1403764-72-6 |
| Nexturastat A |
4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE |
1403783-31-2 |
| RGFP 109 |
RG2833(RGFP109) |
1215493-56-3 |
| Oclacitinib Maleate(PF-03394197) |
马来酸奥拉替尼 |
1208319-27-0 |
| BI-847325 |
BI-847325 |
1207293-36-4 |
| 6-broMo-4-Methoxypyrazolo[1,5-a]pyridine |
6-溴-4-甲氧基吡唑并[1,5-A]吡啶 |
1207557-36-5 |
| HSF1A |
HSF1 ACTIVATOR;HSF1A;CAS 1196723-93-9 |
1196723-93-9 |
| BP-1-102 |
4-(N-(4-环己基苄基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羟基苯甲酸 |
1334493-07-0 |
| 1H-1,2,3-Triazole-1-acetic acid, 4-[[bis[[1-(1,1-diMethylethyl)-1H-1,2,3-triazol-4-yl]Methyl]aMino]Methyl]- |
BTTAA |
1334179-85-9 |
| N-(2-(diMethylaMino)ethyl)-1-(3-((4-((2-Methyl-1H-indol-5-yl)oxy)pyriMidin-2-yl)aMino)phenyl)MethanesulfonaMide |
5-羟基-2-甲基吲哚 |
1308672-74-3 |
| 3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone |
RAD51 INHIBITOR B02 |
1290541-46-6 |
| 1H-Pyrazol-3-aMine, 5-fluoro- |
5-氟-1H-吡唑-3-胺 |
1159196-53-8 |
| 7-(5-(1,5-dichloropentan-3-yl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)-N-hydroxyheptanaMide |
EDO-S101 |
1236199-60-2 |
| 5-(4-(2-(3-METHOXYPHENYL)-2-OXOETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE |
1133819-87-0 |
1133819-87-0 |
| SKLB1002 |
SKLB1002 |
1225451-84-2 |
| Ruxolitinib phosphate |
鲁索利替尼磷酸盐 |
1092939-17-7 |
| 2-PICOLINE-3-BORONIC ACID HCL |
2-甲基吡啶-3-硼酸盐酸盐 |
1072952-34-1 |
| (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid |
艾沙佐米 |
1072833-77-2 |
